Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy - pulmonary and vascular endothelial function: an exploratory analysis
van der Schoot, G. G. F., Ormel, H. L., Westerink, N-D. L., Wempe, J. B., Lefrandt, J. D., May, A. M., Vrieling, A. H., Meijer, C., Gietema, J. A. & Walenkamp, A. M. E., 27-Oct-2023, (E-pub ahead of print) In: Journal of cancer research and clinical oncology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST
de Mestier, L., Resche-Rigon, M., Dromain, C., Lamarca, A., La Salvia, A., de Baker, L., Fehrenbach, U., Pusceddu, S., Colao, A., Borbath, I., de Haas, R., Rinzivillo, M., Zerbi, A., Funicelli, L., de Herder, W. W., Selberherr, A., Wagner, A. D., Manoharan, P., De Cima, A., Lybaert, W., & 12 others, 2023, In: Journal of Neuroendocrinology. 35, 6, 12 p., e13311.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)8 Downloads (Pure) -
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Lassman, A. B., Wen, P. Y., van den Bent, M. J., Plotkin, S. R., Walenkamp, A. M. E., Green, A. L., Li, K., Walker, C. J., Chang, H., Tamir, S., Henegar, L., Shen, Y., Alvarez, M. J., Califano, A., Landesman, Y., Kauffman, M. G., Shacham, S. & Mau-Sørensen, M., 1-Feb-2022, In: Clinical Cancer Research. 28, 3, p. 452–460 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Citations (Scopus)33 Downloads (Pure) -
Centralized proton therapy for medulloblastoma; an evaluation of the care infrastructure.
Nauta, J. F., Maduro, J., Bannink-Gawryszuk, A., Bosma, I., Bromberg, J., Enting, R., Fock, A., Heesters, M., Hoeben, B., Hooimeijer, L., Hoving, E., Janssens, G., Jeltema, H., Matysiak, W., Molenbuur, B., Nuver, J., Plasschaert, S., Tissing, W., van der Salm, N., van Rij, C., & 4 others, May-2022, In: Radiotherapy and Oncology. 170, p. S34-S35 2 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
Veenstra, E. B., Brouwers, A. H., de Groot, D. J. A., Hofland, J., Walenkamp, A. M. E., Brabander, T., Zandee, W. T. & Noordzij, W., 15-Jun-2022, In: European Journal of Hybrid Imaging. 6, 1, 11 p., 12.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Citations (Scopus)25 Downloads (Pure)
Activities
-
Follow-up of NET
Annemiek Walenkamp-Hageman (Invited speaker)
15-Jul-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
Role of (international) biobanking in rare cancer research
Annemiek Walenkamp-Hageman (Invited speaker)
17-Nov-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
How to proceed with national biobanking in rare cancer research
Annemiek Walenkamp-Hageman (Invited speaker)
2022Activity: Talk and presentation › Professional or public presentation › Professional
-
Infrastructure for rare cancers in the Netherlands: Towards a comprehensive platform for early detection and treatment of rare cancers: FORCE
Annemiek Walenkamp-Hageman (Invited speaker)
1-Mar-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Supervision of PhD student Cyrillo Brahm
Henk M. W. Verheul (Supervisor), Annemiek Walenkamp-Hageman (Supervisor), Rudolf Fehrmann (Co-supervisor) & A. Westerman (Co-supervisor)
3-Jun-2021Activity: Examination, teaching and supervision › Examination, teaching and supervision external institution › Academic
Datasets
-
Additional file 10 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Schäfer, G. (Contributor), Haybaeck, J. (Contributor), Daum, S. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Pircher, A. (Contributor), Noureen, A. (Contributor), Plattner, C. (Contributor), Timmer-Bosscha, H. (Contributor), Goveia, J. (Contributor), Salcher, S. (Contributor), Walenkamp-Hageman, A. (Contributor), Beatovic, A. (Contributor), Sopper, S. (Contributor), Trajanoski, Z. (Contributor), Moisse, M. (Contributor), Thaler, S. (Contributor) & Perner, S. (Contributor), figshare Academic Research System, 19-Jun-2022
DOI: 10.6084/m9.figshare.20098784.v1
Dataset
-
Additional file 6 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Moisse, M. (Contributor), Trajanoski, Z. (Contributor), Thaler, S. (Contributor), Schäfer, G. (Contributor), Walenkamp-Hageman, A. (Contributor), Daum, S. (Contributor), Sopper, S. (Contributor), Timmer-Bosscha, H. (Contributor), Pircher, A. (Contributor), Haybaeck, J. (Contributor), Krogsdam, A. (Contributor), Klocker, H. (Contributor), Goveia, J. (Contributor), Beatovic, A. (Contributor), Noureen, A. (Contributor), Keller, M. A. (Contributor), Wolf, D. (Contributor), Plattner, C. (Contributor), Salcher, S. (Contributor) & Perner, S. (Contributor), figshare Academic Research System, 19-Jun-2022
DOI: 10.6084/m9.figshare.20098802.v1
Dataset
-
Additional file 8 of Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
Heidegger, I. (Contributor), Fotakis, G. (Contributor), Offermann, A. (Contributor), Schäfer, G. (Contributor), Klocker, H. (Contributor), Daum, S. (Contributor), Salcher, S. (Contributor), Noureen, A. (Contributor), Goveia, J. (Contributor), Krogsdam, A. (Contributor), Beatovic, A. (Contributor), Timmer-Bosscha, H. (Contributor), Trajanoski, Z. (Contributor), Thaler, S. (Contributor), Pircher, A. (Contributor), Moisse, M. (Contributor), Perner, S. (Contributor), Plattner, C. (Contributor), Wolf, D. (Contributor), Walenkamp-Hageman, A. (Contributor), Sopper, S. (Contributor), Haybaeck, J. (Contributor) & Keller, M. A. (Contributor), figshare Academic Research System, 19-Jun-2022
DOI: 10.6084/m9.figshare.20098808.v1
Dataset
-
Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Nienhuis, H. (Contributor), Van Leeuwen-Stok, E. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), Qiu, S. (Contributor), Van Deurzen, C. H. M. (Contributor), Timmer-Bosscha, H. (Contributor), de Vries, L. (Contributor), Walenkamp-Hageman, A. (Contributor) & Schröder, C. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004491.v1, https://doi.org/10.6084%2Fm9.figshare.12004491.v1
Dataset
-
Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Timmer-Bosscha, H. (Contributor), Van Deurzen, C. H. M. (Contributor), Van Leeuwen-Stok, E. (Contributor), van der Vegt, B. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Qiu, S. (Contributor), Schröder, C. (Contributor), de Vries, L. (Contributor) & Walenkamp-Hageman, A. (Contributor), University of Groningen, 19-Mar-2020
DOI: 10.6084/m9.figshare.12004500.v1, https://doi.org/10.6084%2Fm9.figshare.12004500.v1
Dataset
Press/Media
-
‘Zonder stok achter de deur was ik eerder gestopt’
15/12/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
El ejercicio durante la quimioterapia ayuda en la recuperación del corazón y los pulmones
20/10/2022
1 Media contribution
Press/Media: Expert Comment › Professional
-
Exercise during chemo may improve heart, lung function
19/10/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Exercise During Chemo Helps Your Heart, Lungs Recover
19/10/2022
2 items of Media coverage
Press/Media: Expert Comment › Popular
-
Bewegung während der Chemotherapie hilft Ihrem Herzen und Ihrer Lunge, sich zu erholen
18/10/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
Prizes
-
Infrastructural grant FORCE; Infrastructure for rare cancer in the Netherlands (€3.200.000,--)
Walenkamp-Hageman, Annemiek (Recipient), 2021
Prize: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary website to inform patients with neuroendocrine tumors”. PI. (€50.000,--)
Walenkamp-Hageman, Annemiek (Recipient), 2020
Prize: Other distinction › Academic
-
Grant: UMCG Cancer Researchfund: “Non-invasive evaluation of oxidative muscle metabolism in patients with testicular cancer enrolled in the UMCG ACT trial” (€3.000,--)
Walenkamp-Hageman, Annemiek (Recipient), 2020
Prize: Other distinction › Academic
-
Educational grant IPSEN: “Multi-disciplinary approach in neuroendocrine tumor patients”. PI. (€200.000,--)
Walenkamp-Hageman, Annemiek (Recipient), 2017
Prize: Other distinction › Academic
-
Educational grant Novartis: “Towards optimal personalized diet and vitamin supplementation in NET patients”. PI. (€220.000,--)
Walenkamp-Hageman, Annemiek (Recipient), 2014
Prize: Other distinction › Academic